| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| VU591 |
6-NITRO-2-[(6-NITRO-1H-BENZIMIDAZOL-2-YL)METHOXYMETHYL]-1H-BENZIMIDAZOLE HYDROCHLORIDE |
1222810-74-3 |
詳細
|
| NS3623 |
NS 3623 |
343630-41-1 |
詳細
|
| NS5806 |
NS 5806 |
426834-69-7 |
詳細
|
| DMP-543 |
10,10-雙[(2-氟-4-吡啶基)甲基]-9(10H)-蒽酮 |
160588-45-4 |
詳細
|
| BMS-191011 |
3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE |
202821-81-6 |
詳細
|
| PD-118057 |
PD-118057 |
313674-97-4 |
詳細
|
| BL-1249 |
BL 1249 |
18200-13-0 |
詳細
|
| Broflanilide |
溴蟲氟苯雙酰胺 |
1207727-04-5 |
詳細
|
| Fluxametamide |
4-[5-(3,5-二氯苯基)-4,5-二氫-5-(三氟甲基)-3- 異惡唑基]-N-[(甲氧基氨基)亞甲基]-2-甲基苯 甲酰胺 |
928783-29-3 |
詳細
|
| LY3130481 |
LY3130481 |
1610802-47-5 |
詳細
|
| NSC 15364 |
1,3-二(4-氨基苯基)脲 |
4550-72-5 |
詳細
|
| Tulrampator |
1038984-31-4 |
1038984-31-4 |
詳細
|
| Licogliflozin |
1291094-73-9 |
1291094-73-9 |
詳細
|
| Aniracetam |
阿尼西坦 |
72432-10-1 |
詳細
|
| Mibampator |
MIBAMPATOR |
375345-95-2 |
詳細
|
| LY450108 |
N-[4-[(1R)-1-甲基-2-[[異丙基磺?；鵠氨基]乙基]苯基]-3,5-二氟苯基甲酰胺 |
376594-67-1 |
詳細
|
| S 18986 |
S 18986 |
175340-20-2 |
詳細
|
| Farampator |
CX691 |
211735-76-1 |
詳細
|
| VU0463271 |
VU 0463271 |
1391737-01-1 |
詳細
|
| ZSET1446 |
887603-94-3 |
887603-94-3 |
詳細
|
| CLP257 |
化合物CLP257 |
1181081-71-9 |
詳細
|
| Flindokalner |
(3S)-3-(5-chloro-2-methoxy-phenyl)-3-fluoro-6-(trifluoromethyl)-1H-ind ol-2-one |
187523-35-9 |
詳細
|
| VU591 hydrochloride |
VU 591 HYDROCHLORIDE |
1315380-70-1 |
詳細
|
| PSEM 89S TFA |
化合物PSEM 89S TFA |
1336913-03-1 |
詳細
|
| HC-070 |
化合物 T15465 |
1628291-95-1 |
詳細
|
| TRPM8 antagonist 2 |
TRPM8 拮抗劑 |
259674-19-6 |
詳細
|
| NF449 octasodium |
NF449 |
627034-85-9 |
詳細
|
| IK1 inhibitor PA-6 |
PA 6 |
500715-03-7 |
詳細
|
| VU0529331 |
VU0529331 |
1286725-49-2 |
詳細
|
| ATP synthase inhibitor 1 |
ATP SYNTHASE INHIBITOR 1 |
1023043-30-2 |
詳細
|
| ACT-709478 |
化合物 T14120 |
1838651-58-3 |
詳細
|
| Etiocholanolone |
3a-羥基-5b-雄甾烷-17-酮 |
53-42-9 |
詳細
|
| NS19504 |
5-[(4-BROMOPHENYL)METHYL]-1,3-THIAZOL-2-AMINE |
327062-46-4 |
詳細
|
| Pozanicline dihydrochloride |
Pyridine, 2-methyl-3-[(2S)-2-pyrrolidinylmethoxy]-, dihydrochloride |
161416-61-1 |
詳細
|
| ASP2535 |
4-[3-(1-Methylethyl)-5-(6-phenyl-3-pyridinyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole |
374886-51-8 |
詳細
|
| TC-I 2014 |
3-[7-(TRIFLUOROMETHYL)-5-[2-(TRIFLUOROMETHYL)PHENYL]-1H-BENZIMIDAZOL-2-YL]-1-OXA-2-AZASPIRO[4.5]DEC-2-ENE |
1221349-53-6 |
詳細
|
| Topiramate D12 |
托吡酯-D12 |
1279037-95-4 |
詳細
|
| MK6-83 |
MK6-83 |
1062271-24-2 |
詳細
|
| Dianicline dihydrochloride |
DIANICLINE DIHYDROCHLORIDE |
292634-27-6 |
詳細
|
| Icilin |
ICILIN |
36945-98-9 |
詳細
|
| GSK1702934A |
1,3-Dihydro-1-[1-[(5,6,7,8-tetrahydro-4H-cyclohepta[b]thien-2-yl)carbonyl]-4-piperidinyl]-2H-benzimidazol-2-one |
924377-85-5 |
詳細
|
| Synta66 |
化合物SYNTA66 |
835904-51-3 |
詳細
|
| (Rac)-NMDAR antagonist 1 |
化合物 (RAC)-NMDAR ANTAGONIST 1 |
2435557-99-4 |
詳細
|
| Pinaverium bromide |
匹維溴銨 |
53251-94-8 |
詳細
|
| PTI-428 |
PTI-428 |
1953130-87-4 |
詳細
|
| JNJ-61432059 |
JNJ-61432059 |
2035814-50-5 |
詳細
|
| TTA-A2 |
2(4-環(huán)丙基苯基)-N[(1R)- 1 -[5 -(2,2,2-三氟乙氧基)吡啶-2-基]乙基]乙酰胺 |
953778-63-7 |
詳細
|
| BI-749327 |
BI-749327 |
2361241-23-6 |
詳細
|
| Lidoflazine |
利多氟嗪 |
3416-26-0 |
詳細
|
| Aminooxyacetic acid hemihydrochloride |
羧甲基羥胺半鹽酸鹽 |
2921-14-4 |
詳細
|
| Mirogabalin besylate |
10928苯磺酸鹽 |
1138245-21-2 |
詳細
|
| Pivagabine |
匹伐加賓 |
69542-93-4 |
詳細
|
| AM-0902 |
AM0902 |
1883711-97-4 |
詳細
|
| Sipatrigine |
西帕曲近 |
130800-90-7 |
詳細
|
| A-967079 |
(1E,3E)-1-(4-氟苯基)-2-甲基-1-戊烯-3-酮肟 |
1170613-55-4 |
詳細
|
| Pyr3 |
1160514-60-2 |
1160514-60-2 |
詳細
|
| P-1075 |
化合物P-1075 |
60559-98-0 |
詳細
|
| PF-06305591 |
PF-06305591 |
1449473-97-5 |
詳細
|
| GT 949 |
GT 949 |
460330-27-2 |
詳細
|
| (2R/S)-6-PNG |
2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
68682-01-9 |
詳細
|
| 3-Methyl-GABA |
化合物 T22509 |
1216629-00-3 |
詳細
|
| Hyperforin dicyclohexylammonium salt |
貫葉金絲桃素二環(huán)己基銨鹽 |
238074-03-8 |
詳細
|
| Metaflumizone |
氰氟蟲腙 |
139968-49-3 |
詳細
|
| ML753286 |
ML753286 |
1699720-89-2 |
詳細
|
| Lotilaner |
洛替拉納 |
1369852-71-0 |
詳細
|
| Bifenazate |
聯(lián)苯肼酯 |
149877-41-8 |
詳細
|
| GLPG2451 |
GLPG2451 |
2055015-61-5 |
詳細
|
| JNJ-54175446 |
1627902-21-9 |
1627902-21-9 |
詳細
|
| AUT1 |
AUT1 |
1311136-84-1 |
詳細
|
| N-(p-amylcinnamoyl) Anthranilic Acid |
2-(3-(4-戊基苯基)丙烯酰胺基)苯甲酸 |
110683-10-8 |
詳細
|
| Tifenazoxide |
8-chloro-N-(1-methylcyclopropyl)-2,2-dioxo-2$l^{6},9-dithia-3,5-diazab icyclo[4.3.0]nona-3,7,10-trien-4-amine |
279215-43-9 |
詳細
|
| Cav 2.2 blocker 1 |
CAV 2.2 BLOCKER 1 |
1567335-29-8 |
詳細
|
| GDC-0276 |
GDC0276 |
1494581-70-2 |
詳細
|
| (-)-(S)-B-973B |
CS-2844 |
2244989-34-0 |
詳細
|
| ML67-33 |
ML67-33 |
1443290-89-8 |
詳細
|
| CGP 36742 |
CGP 36742 |
123690-78-8 |
詳細
|
| Tipepidine hydrochloride |
TIPEPIDINE HYDROCHLORIDE |
1449686-84-3 |
詳細
|
| MRS 1523 |
MRS 1523 |
212329-37-8 |
詳細
|
| A-867744 |
4-[5-(4-氯苯基)-2-甲基-3-丙?；量?1-基]苯磺酰胺 |
1000279-69-5 |
詳細
|
| CCMI |
CCMI |
917837-54-8 |
詳細
|
| PNU-120596 |
PNU 120596 |
501925-31-1 |
詳細
|
| Valnoctamide |
戊諾酰胺 |
4171-13-5 |
詳細
|
| ICA-27243 |
325457-89-4 |
325457-89-4 |
詳細
|
| BAY-8002 |
2-(2-氯-5-(苯基磺酰基)苯甲酰氨基)苯甲酸 |
724440-27-1 |
詳細
|
| VU0134992 hydrochloride |
VU0134992(hydrochloride) |
1052515-91-9 |
詳細
|
| Aurintricarboxylic acid |
金精三羧酸 |
4431-00-9 |
詳細
|
| ML418 |
ML418 |
1928763-08-9 |
詳細
|
| Rostafuroxin |
ROSTAFUROXIN |
156722-18-8 |
詳細
|
| KGA-2727 |
KGA2727 |
666842-36-0 |
詳細
|
| A-1165442 |
1221443-94-2 |
1221443-94-2 |
詳細
|
| (Rac)-ABT-202 dihydrochloride |
1-(pyridin-3-yl)pyrrolidin-3-amine dihydrochloride |
1258641-38-1 |
詳細
|
| GV-58 |
(2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇 |
1402821-41-3 |
詳細
|
| Efonidipine hydrochloride monoethanolate |
依福地平 |
111011-76-8 |
詳細
|
| CFM-2 |
178616-26-7 |
178616-26-7 |
詳細
|
| Pyr6 |
245747-08-4 |
245747-08-4 |
詳細
|
| ORM-10962 |
1-Piperidineacetamide, N-[6-[(3,4-dihydro-2-phenyl-2H-1-benzopyran-6-yl)oxy]-3-pyridinyl]-4-hydroxy- |
763926-98-3 |
詳細
|
| GSK205 |
GSK205 |
1263068-83-2 |
詳細
|
| Roemerine |
蓮堿 |
548-08-3 |
詳細
|
| SKA-31 |
NAPHTHO[1,2-D]THIAZOL-2-AMINE |
40172-65-4 |
詳細
|
| 5-Hydroxylansoprazole |
5-羥基蘭索拉唑 |
131926-98-2 |
詳細
|